Cerebrolysin and Recovery after Stroke (CARS): A randomized, placebo-controlled, double-blind, multicenter, phase ii clinical study

被引:0
|
作者
Muresanu, D. [1 ]
Heiss, W. D. [2 ]
Bajenaru, O. [3 ]
Popescu, C. D. [4 ]
Vester, J. [5 ]
Guekht, A. [6 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Neurosci, Cluj Napoca, Romania
[2] Max Planck Inst Neurol Res, Neurol, D-50931 Cologne, Germany
[3] Carol Davila Univ Med & Pharm, Neurol, Bucharest, Romania
[4] Carol Davila Univ Med & Pharm, Neurol, Iasi, Romania
[5] IDV Data Anal & Study Planning, Biometry & Clin Res, Krailing, Germany
[6] Russian State Med Univ Moscow City Hosp, Neurol & Neurosurg, Moscow, Russia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ESOC-1155
引用
收藏
页码:92 / 92
页数:1
相关论文
共 50 条
  • [1] Cerebrolysin and recovery after stroke (CARS 2): a randomized, placebo-controlled, double-blind, multicenter clinical study
    Guekht, A.
    Heiss, D.
    Gusev, E.
    Vester, J.
    Doppler, E.
    Muresanu, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E103 - E103
  • [2] Cerebrolysin and Recovery After Stroke (CARS) A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
    Muresanu, Dafin F.
    Heiss, Wolf-Dieter
    Hoemberg, Volker
    Bajenaru, Ovidiu
    Popescu, Cristian Dinu
    Vester, Johannes C.
    Rahlfs, Volker W.
    Doppler, Edith
    Meier, Dieter
    Moessler, Herbert
    Guekht, Alla
    STROKE, 2016, 47 (01) : 151 - 159
  • [3] Letter by Rezaei and Arjmand Regarding Article, "Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial"
    Rezaei, Yousef
    Arjmand, Nasim
    STROKE, 2016, 47 (05) : e90 - e90
  • [4] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, JY
    Cho, KH
    Oho, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Choi, KD
    Cho, HS
    Lee, HT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2
  • [5] Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Guekht, Alla B.
    Moessler, Herbert
    Novak, Philipp H.
    Gusev, Evgenyi I.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2011, 20 (04): : 310 - 318
  • [6] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, CY
    Cho, K
    Oh, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Lee, S
    Choi, GD
    Cho, H
    Lee, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) : 1566 - 1571
  • [7] A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke
    Skvortsova, VI
    Stakhovskaya, LV
    Gubsky, LV
    Shamalov, NA
    Tikhonova, IV
    Smychkov, AS
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2004, : 51 - 55
  • [8] SULFASALAZINE IN SPONDYLARTHROPATHY - A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    DOUGADOS, M
    VANDERLINDEN, S
    LEIRISALOREPO, M
    HUITFELDT, B
    BERTOUCH, J
    BROOKS, P
    DIJKMANS, B
    EDMONDS, J
    MAJOR, G
    KVIEN, T
    OLIVIERI, I
    VEYS, E
    ZEIDLER, H
    AMOR, B
    CALIN, A
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S92 - S92
  • [9] EFFECT OF PIRACETAM ON RECOVERY AND REHABILITATION AFTER STROKE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    ENDERBY, P
    BROECKX, J
    HOSPERS, W
    SCHILDERMANS, F
    DEBERDT, W
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (04) : 320 - 331
  • [10] Cerebrolysin in Patients With Acute Ischemic Stroke in Asia Results of a Double-Blind, Placebo-Controlled Randomized Trial
    Heiss, Wolf-Dieter
    Brainin, Michael
    Bornstein, Natan M.
    Tuomilehto, Jaakko
    Hong, Zhen
    STROKE, 2012, 43 (03) : 630 - 636